Chugai Pharmaceutical Co., Ltd. 4519.T
JP · Tokyo Stock Exchange · XTKS · stock · Healthcare · website
Chugai Pharmaceutical Co., Ltd. statistics & valuation
Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
Chugai Pharmaceutical Co., Ltd. trades at about 28.6× earnings — near its 10-year norm (10-year range 14.8×–33.4×, median 28.6×).
14.8×
33.4×
Shaded band = 10-year range (14.8×–33.4×); dot = today's 28.6×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 71.1% | 71.0% | 62.8% | 62.2% |
| Operating margin | 47.6% | 46.3% | 39.5% | 42.3% |
| FCF margin | 21.8% | 33.5% | 30.2% | 13.7% |
| Current ratio | 4.23 | 5.53 | 4.74 | 3.15 |
Source: company filings via Yahoo Finance · JP · as of 2025-12-31. Figures in JPY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.